An2 Therapeutics logo

An2 Therapeutics share price today

(ANTX)

An2 Therapeutics share price is $1.26 & ₹107.07 as on 21 Dec 2024, 2.30 'hrs' IST

$1.26

-0.01

(-0.79%)

Market is closed - opens 8 PM, 23 Dec 2024

View live An2 Therapeutics share price in Dollar and Rupees. Guide to invest in An2 Therapeutics from India. Also see the sentimental analysis on Indian investors investing in An2 Therapeutics. Get details on the Indian mutual funds that are investing in An2 Therapeutics. Get Analyst recommendations and forecasts along with all the An2 Therapeutics's financials.

An2 Therapeutics share price movements

  • Today's Low: $1.24
    Today's High: $1.28

    Day's Volatility :3.52%

  • 52 Weeks Low: $0.87
    52 Weeks High: $22.22

    52 Weeks Volatility :96.08%

An2 Therapeutics Returns

PeriodAn2 Therapeutics, Inc.Index (Russel 2000)
3 Months
21.15%
0.0%
6 Months
-39.13%
0.0%
1 Year
-93.95%
0.0%
3 Years
-91.82%
-19.7%

An2 Therapeutics Key Statistics

in dollars & INR

Previous Close
$1.27
Open
$1.25
Today's High
$1.28
Today's Low
$1.235
Market Capitalization
$37.9M
Today's Volume
$105.6K
52 Week High
$22.22
52 Week Low
$0.87
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-1.99
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-69.48%

How to invest in An2 Therapeutics from India?

It is very easy for Indian residents to invest directly in An2 Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the An2 Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for An2 Therapeutics or ANTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of An2 Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of An2 Therapeutics shares which would translate to 0.674 fractional shares of An2 Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like An2 Therapeutics, in just a few clicks!

Returns in An2 Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

An2 Therapeutics investment value today

Current value as on today

₹1,96,150

Returns

₹96,150

(+96.15%)

Returns from An2 Therapeutics Stock

₹93,954 (false-93.95%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards An2 Therapeutics

-33%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for An2 Therapeutics on INDmoney from India has reduced in the last 30 days as on Dec 22, 2024. -33% less investors are searching An2 Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in An2 Therapeutics

  • BML Capital Management LLC

    19.24%

  • RA Capital Management, LLC

    6.69%

  • TCG Crossover Management, LLC

    5.20%

  • Vanguard Group Inc

    3.49%

  • Acuitas Investments, LLC

    1.49%

  • Renaissance Technologies Corp

    1.42%

Analyst Recommendation on An2 Therapeutics

Buy

    72%Buy

    27%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for An2 Therapeutics(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
7
10
Hold
3
4
1
Sell
0
0
0

Analyst Forecast on An2 Therapeutics

What analysts predicted

Upside of 111.64%

Current:

$1.26

Target:

$2.67

Insights on An2 Therapeutics

  • Price Movement

    In the last 7 days, ANTX stock has moved down by -11.9%
  • ANTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 129.4%

An2 Therapeutics Technicals Summary

Sell

Neutral

Buy

An2 Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

An2 Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
An2 Therapeutics, Inc.
-5.97%
-39.13%
-93.95%
-91.82%
-91.82%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.38%
12.23%
86.41%
Biontech Se
4.48%
30.56%
7.97%
-55.71%
237.85%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.37%
26.29%
108.55%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-2.55%
77.79%
80.12%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
An2 Therapeutics, Inc.
NA
NA
NA
-1.45
-0.69
-0.43
NA
4.19
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
An2 Therapeutics, Inc.
Buy
$37.9M
-91.82%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
86.41%
17.51
33.61%
Biontech Se
Buy
$26.7B
237.85%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
108.55%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.12%
32.84
-4.51%

About An2 Therapeutics

an2 therapeutics, inc. is a california-based global health biopharmaceutical company focused on bringing the power of modern biomedical and drug development expertise to provide transformational medicines for patients suffering from infectious diseases. an2 is a mission-driven company, with a vision for humanity to be free from the threat of infectious diseases by addressing the urgent need for new treatments that can save lives across the globe. founded by a small team of biopharmaceutical industry leaders with a passion for global health and experience in infectious disease drug r&d, we strive to bring patients treatments that will restore their health and enable them to live productive lives.
Organization
An2 Therapeutics
Employees
41
CEO
Mr. Eric E. Easom
Industry
Services

Management People of An2 Therapeutics

NameTitle
Mr. Eric E. Easom
Co-Founder, CEO, President & Chairman of the Board
Mr. Joseph S. Zakrzewski
Co-Founder & Chairman of the Board
Ms. Lucy O. Day CPA
CFO, Principal Financial Officer & Principal Accounting Officer
Dr. George Harrison Talbot FACP, M.D.
Co-Founder & Senior Clinical Advisor
Dr. Michael R. K. Alley Ph.D.
Co-Founder & Head of Biology
Dr. Sanjay Chanda Ph.D.
Chief Development Officer

Important FAQs about investing in An2 Therapeutics from India :

What is An2 Therapeutics share price today?

An2 Therapeutics share price today stands at $1.26, Open: $1.25 ; Previous Close: $1.27 ; High: $1.28 ; Low: $1.24 ; 52 Week High: $22.22 ; 52 Week Low: $0.87. The stock opens at $1.25, after a previous close of $1.27. The stock reached a daily high of $1.28 and a low of $1.24, with a 52-week high of $22.22 and a 52-week low of $0.87.

Can Indians buy An2 Therapeutics shares?

Yes, Indians can invest in the An2 Therapeutics (ANTX) from India.

With INDmoney, you can buy An2 Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy An2 Therapeutics at zero transaction cost.

How can I buy An2 Therapeutics shares from India?

It is very easy to buy An2 Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of An2 Therapeutics be purchased?

Yes, you can buy fractional shares of An2 Therapeutics with INDmoney app.

What are the documents required to start investing in An2 Therapeutics stocks?

To start investing in An2 Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of An2 Therapeutics

Today’s highest price of An2 Therapeutics (ANTX) is $1.28.

Today’s lowest price of An2 Therapeutics (ANTX) is $1.24.

What is today's market capitalisation of An2 Therapeutics

Today's market capitalisation of An2 Therapeutics ANTX is 37.9M

What is the 52 Week High and Low Range of An2 Therapeutics

  • 52 Week High

    $22.22

  • 52 Week Low

    $0.87

What are the historical returns of An2 Therapeutics?

  • 1 Month Returns

    -5.97%

  • 3 Months Returns

    -39.13%

  • 1 Year Returns

    -93.95%

  • 5 Years Returns

    -91.82%

Who is the Chief Executive Officer (CEO) of An2 Therapeutics

Mr. Eric E. Easom is the current Chief Executive Officer (CEO) of An2 Therapeutics.